Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease.

Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease.

<h4>Background</h4>Severe acute respiratory coronavirus 2 (SARS-CoV-2) has caused a devastating worldwide pandemic. Hydroxychloroquine (HCQ) has in vitro activity against SARS-CoV-2, but clinical data supporting HCQ for coronavirus disease 2019 (COVID-19) are limited.<h4>Methods<...

Full description

Bibliographic Details
Main Authors: Michael J Satlin, Parag Goyal, Reed Magleby, Grace A Maldarelli, Khanh Pham, Maiko Kondo, Edward J Schenck, Hanna Rennert, Lars F Westblade, Justin J Choi, Monika M Safford, Roy M Gulick
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2020-01-01
Series:PLoS ONE
Online Access:https://doi.org/10.1371/journal.pone.0236778

Internet

https://doi.org/10.1371/journal.pone.0236778

Similar Items